+ Follow
image by unsplash.com

Why Nipah Virus Alarms the World

Nipah virus is a black swan infectious disease that is very dangerous, but at the same time, it is a serious health threat to people around the world, even when the outbreak is relatively small. The most dangerous thing about Nipah is that it has a very high mortality rate, with the mortality rate ranging between about 40 to as high as 75 per cent based on the outbreak and how the victims were exposed to medicine. A single confirmed case can often provoke emergency responses on behalf of the public health. The first outbreak of the Nipah virus was reported in 1998 in an outbreak in Malaysia and has since then reoccurred in South Asia, particularly in Bangladesh and India. Over the last few years, there have been several outbreaks in the Indian state of Kerala, which necessitated the need to contain and control the outbreak so that it would not spread further.

The Natural Host: Why Fruit Bats Remain Unaffected

The reservoir host of the Nipah virus is the fruit bats or flying foxes, which are the ones that are naturally circulating. These bats are capable of carrying and shedding the virus throughout their lives without manifesting the disease. The reason behind this is that most of the bat immune systems are uniquely designed to manage viral replication and to restrain the destructive inflammation. In contrast to humans, a kind of homeostasis of the antiviral response is ensured by bats, which prevents the excessive development of the immune response. The immune system of a human being is, however, very vigorous and, in most cases, uncontrollable and as such, the body causes an extreme amount of tissue damage and a complex condition, which is life-threatening in nature.

Transmission Pathways from Animals to Humans

Human infection is brought about by the passage of the virus between animals and people, in most of the instances by exposure to contaminated food sources from bats. There has also been a strong association of outbreaks with the ingestion of raw date palm sap that has been contaminated by bat saliva or urine, especially in Bangladesh and certain regions in India. Pig contact is also another method through which the virus can be passed over to people with infected animals like pigs, which were significant to the initial outbreak in Malaysia. Upon entry into human populations, the Nipah virus can be transmitted among people by means of close human contact, respiratory, and body fluids. Even though its spread is not as widespread as that of influenza or COVID-19, in the present case, household caregivers and medical professionals pose the greatest risk during an outbreak.

Viral Structure and Entry into the Human Body

Nipah virus is a single-stranded RNA virus, which is classified in the family Paramyxoviridae. It usually gets into the human organism via the mouth, nose, or eyes and first of all infects the cells of the respiratory system. Once infected, this virus spreads to other body organs, especially the lungs and the brain, via the bloodstream. Within the human cells, the virus takes control of the regular cell process and makes the cell generate plenty of new viral particles. This process later kills the infected cells, which will lead to the general destruction of tissues and organ failures.

When the Immune System Becomes the Enemy

The response of the human immune system is among the most hazardous factors of the Nipah virus infection. Cytokines are large amounts of inflammatory signalling molecules that are released by immune cells in a bid to destroy the virus. This response in extreme cases is excessive and leads to cytokine storm. Rather than settling the body, this massive inflammation destroys blood vessels, interferes with the blood-brain barrier, and leads to leakage of the fluid in the lung tissue. Therefore, patients experience encephalitis, the inflammation of the brain, as well as extreme distress in the respiratory system. Much of the harm that is observed in deadly cases is not actually due to the virus itself, but as a result of the overreaction of the immune system to the body.

Clinical Course and Symptoms of Infection

The incubation period of four to twenty-one days is reported, but the symptoms of Nipah virus infection normally manifest between four and fourteen days following exposure. No early symptoms are usually associated with this condition, and symptoms are similar to those of common viral illnesses and manifest as fever, headache, muscle aches, sore throat and vomiting. The disease becomes acute in most of the patients since the virus spreads to the brain and lungs. There are neurological symptoms like confusion, changes in consciousness, convulsions, abnormal behaviour, and coma. Simultaneously, lung inflammation may cause acute respiratory distress and perilously low oxygen content. The mortality rate may be as high as death within seven days after the onset.

Repeated Outbreaks in Kerala, India

Kerala is a good illustration of the riskiness of the Nipah virus and the significance of preparedness for people's health. In the recent outbreaks of 2023 to 2025, the outbreak was contained due to the rapid testing, isolation, and contact tracing as well. But even with this, deaths

were high. In a reported outbreak, the majority of the individuals who were infected succumbed to death even after the administration of intense medical treatment. The schools were shut, the movement was limited, and the procurement of complete protective equipment became obligatory among the healthcare workers. Such outbreaks prove that the containment measures could only partially inhibit the virus spread, but could not achieve total death prevention because of the severity of the virus and the absence of specific treatment.

Long-Term Consequences for Survivors

It has protracted health issues, especially experienced by survivors of Nipah virus infection, caused by brain damage. Most of them experience chronic memory impairment, inability to concentrate, personality changes and epileptic disorders. Other physical conditions like weakness, walking problems and speech problems are also experienced. Some of the reported psychological effects are depression and anxiety among some of the survivors. There are rare cases when people contract late-onset encephalitis months or even years following what seems to be a successful recovery, implying that the immunity controller has not succeeded in restoring normalcy.

Treatment Limitations and Ongoing Research

Currently, the Nipah virus has no particular antiviral agent or approved vaccine to be used. The medical care is fully concerned with the supportive treatment, such as oxygen delivery, fluid control, seizure control, and intensive care observation. Hospitalisation, immediate supportive care and early hospitalisation are very important factors in improving survival. The current studies are looking at the treatment of experimental therapy through monoclonal antibodies and the development of vaccine candidates, which are yet to be available as a regular therapy.

Prevention as the Primary Defense

Nipah virus has limited treatment options, and therefore, prevention has been the best approach to deal with it. Education in health serves a fundamental role in eliminating risk, especially where outbreaks are commonly experienced. It is also observed that avoiding the raw date palm sap, washing of the fruits, contact with bats and sick animals, strict hygiene and minimisation of close contact with victims in case of an outbreak have been effective in reducing the spread of the illness.

A Disease Shaped by Immune Overreaction

Nipah virus illustrates a troubling paradox in infectious disease: the immune system’s attempt to protect the body can instead become a major cause of harm. While the virus itself is highly dangerous, the severe inflammation triggered by the human immune response is a key factor behind the high death rate and long-term neurological damage. Until effective vaccines and treatments become widely available, early detection, supportive medical care, and strong preventive measures remain essential to reducing the impact of this deadly virus.

.    .    .

References:

Discus